Arcus Capital Partners’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
AIM
NAMA
SOMRS
Arcus Capital Partners's TDOC Position: Q1 2023 in Review
Arcus Capital Partners sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 147 shares — an estimated $3.48K sold.
Arcus Capital Partners first reported a position in TDOC in Q4 2022 and held it in 1 quarter. The position peaked at $3.48K in Q4 2022. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.
- Arcus Capital Partners reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
- Arcus Capital Partners sold 147 Teladoc Health shares in Q1 2023, an estimated $3.48K.
- Arcus Capital Partners first reported a position in Teladoc Health in Q4 2022 and held it in 1 quarter.
- Arcus Capital Partners's Teladoc Health position peaked at $3.48K in Q4 2022.
- 429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.
Based on Arcus Capital Partners's 13F filing for Q1 2023, filed 9 May 2023.